Pregnancy and Chagas Disease: Benznidazole’s Impact on Pregnancy and Newborns: A Report of Four Cases
Author(s) -
Cristina Vázquez,
Elisa GarcíaVázquez,
Bartolomé Carrilero,
Marina Simón,
Fuensanta Franco,
M. Asunción Iborra,
Luis J. Gil-Gallardo,
Manuel Segovia
Publication year - 2020
Publication title -
american journal of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.015
H-Index - 151
eISSN - 1476-1645
pISSN - 0002-9637
DOI - 10.4269/ajtmh.19-0348
Subject(s) - benznidazole , pregnancy , chagas disease , offspring , trypanosoma cruzi , medicine , disease , serology , obstetrics , public health , pediatrics , immunology , biology , pathology , antibody , parasite hosting , computer science , genetics , world wide web
In recent decades and because of migration, Chagas disease has become a global public health problem. A significant focus has been placed on pregnant women who can transmit the disease to their offspring. Here, we report four cases of women who did not know that they were pregnant while they were being treated with benznidazole. A diagnosis was established according to serology and Trypanosoma cruzi polymerase chain reaction (PCR)-standardized tests. Treatment was discontinued when pregnancy was confirmed, and a thorough follow-up was carried out. Although each case was different, none of the mothers developed health problems during pregnancy, and their newborns were delivered without any teratogenic effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom